Cargando…

Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass

OBJECTIVE: Growth differentiation factor-15 (GDF-15) has been identified as a strong marker of cardiovascular disease; however, no data are available concerning the role of GDF-15 in the occurrence of organ dysfunction during coronary artery bypass grafting (CABG) associated with cardiopulmonary byp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahli, Abdelkader, Guenancia, Charles, Zeller, Marianne, Grosjean, Sandrine, Stamboul, Karim, Rochette, Luc, Girard, Claude, Vergely, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149498/
https://www.ncbi.nlm.nih.gov/pubmed/25171167
http://dx.doi.org/10.1371/journal.pone.0105759
_version_ 1782332768647118848
author Kahli, Abdelkader
Guenancia, Charles
Zeller, Marianne
Grosjean, Sandrine
Stamboul, Karim
Rochette, Luc
Girard, Claude
Vergely, Catherine
author_facet Kahli, Abdelkader
Guenancia, Charles
Zeller, Marianne
Grosjean, Sandrine
Stamboul, Karim
Rochette, Luc
Girard, Claude
Vergely, Catherine
author_sort Kahli, Abdelkader
collection PubMed
description OBJECTIVE: Growth differentiation factor-15 (GDF-15) has been identified as a strong marker of cardiovascular disease; however, no data are available concerning the role of GDF-15 in the occurrence of organ dysfunction during coronary artery bypass grafting (CABG) associated with cardiopulmonary bypass (CPB). METHODS: Five arterial blood samples were taken sequentially in 34 patients from anesthesia induction (IND) until 24 h after arrival at the intensive care unit (ICU). Plasma levels of GDF-15, follistatin-like 1 (FLST1), myeloperoxidases (MPO), hydroperoxides and plasma antioxidant status (PAS) were measured at each time-point. Markers of cardiac (cardiac-troponin I, cTnI) and renal dysfunction (neutrophil gelatinase-associated lipocalin, NGAL) and other classical biological factors and clinical data were measured. RESULTS: Plasma GDF-15 levels increased gradually during and after surgery, reaching nearly three times the IND levels in the ICU (3,075±284 ng/L vs. 1,061±90 ng/L, p<0.001). Plasma MPO levels increased dramatically during surgery, attaining their highest level after unclamping (UNCLAMP) (49±11 ng/mL vs. 1,679±153 ng/mL, p<0.001) while PAS significantly decreased between IND and UNCLAMP (p<0.05), confirming the high oxidative status induced by this surgical procedure. ICU levels of GDF-15 correlated positively with cTnI and NGAL (p = 0.006 and p = 0.036, respectively), and also with hemoglobin and estimated glomerular filtration rate (eGFR). Among all the post-operative biomarkers available, only eGFR, NGAL and GDF-15 measured at ICU arrival were significantly associated with the onset of acute kidney injury (AKI). Patients with a EuroSCORE >3 were shown to have higher GDF-15 levels. CONCLUSIONS: During cardiac surgery associated with CPB, GDF-15 levels increased substantially and were associated with markers of cardiac injury and renal dysfunction.
format Online
Article
Text
id pubmed-4149498
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41494982014-09-03 Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass Kahli, Abdelkader Guenancia, Charles Zeller, Marianne Grosjean, Sandrine Stamboul, Karim Rochette, Luc Girard, Claude Vergely, Catherine PLoS One Research Article OBJECTIVE: Growth differentiation factor-15 (GDF-15) has been identified as a strong marker of cardiovascular disease; however, no data are available concerning the role of GDF-15 in the occurrence of organ dysfunction during coronary artery bypass grafting (CABG) associated with cardiopulmonary bypass (CPB). METHODS: Five arterial blood samples were taken sequentially in 34 patients from anesthesia induction (IND) until 24 h after arrival at the intensive care unit (ICU). Plasma levels of GDF-15, follistatin-like 1 (FLST1), myeloperoxidases (MPO), hydroperoxides and plasma antioxidant status (PAS) were measured at each time-point. Markers of cardiac (cardiac-troponin I, cTnI) and renal dysfunction (neutrophil gelatinase-associated lipocalin, NGAL) and other classical biological factors and clinical data were measured. RESULTS: Plasma GDF-15 levels increased gradually during and after surgery, reaching nearly three times the IND levels in the ICU (3,075±284 ng/L vs. 1,061±90 ng/L, p<0.001). Plasma MPO levels increased dramatically during surgery, attaining their highest level after unclamping (UNCLAMP) (49±11 ng/mL vs. 1,679±153 ng/mL, p<0.001) while PAS significantly decreased between IND and UNCLAMP (p<0.05), confirming the high oxidative status induced by this surgical procedure. ICU levels of GDF-15 correlated positively with cTnI and NGAL (p = 0.006 and p = 0.036, respectively), and also with hemoglobin and estimated glomerular filtration rate (eGFR). Among all the post-operative biomarkers available, only eGFR, NGAL and GDF-15 measured at ICU arrival were significantly associated with the onset of acute kidney injury (AKI). Patients with a EuroSCORE >3 were shown to have higher GDF-15 levels. CONCLUSIONS: During cardiac surgery associated with CPB, GDF-15 levels increased substantially and were associated with markers of cardiac injury and renal dysfunction. Public Library of Science 2014-08-29 /pmc/articles/PMC4149498/ /pubmed/25171167 http://dx.doi.org/10.1371/journal.pone.0105759 Text en © 2014 Kahli et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kahli, Abdelkader
Guenancia, Charles
Zeller, Marianne
Grosjean, Sandrine
Stamboul, Karim
Rochette, Luc
Girard, Claude
Vergely, Catherine
Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
title Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
title_full Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
title_fullStr Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
title_full_unstemmed Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
title_short Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
title_sort growth differentiation factor-15 (gdf-15) levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149498/
https://www.ncbi.nlm.nih.gov/pubmed/25171167
http://dx.doi.org/10.1371/journal.pone.0105759
work_keys_str_mv AT kahliabdelkader growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass
AT guenanciacharles growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass
AT zellermarianne growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass
AT grosjeansandrine growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass
AT stamboulkarim growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass
AT rochetteluc growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass
AT girardclaude growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass
AT vergelycatherine growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass